ETV4 Mediates Dosage-Dependent Prostate Tumor Initiation and Cooperates with p53 Loss to Generate Prostate Cancer

Researchers generated a genetically engineered mouse with prostate-specific expression of the ETS factor, ETV4, at lower and higher protein dosage through mutation of its degron.